Judge blocks Sanofi, Regeneron from selling cholesterol drug

(Reuters) - A federal judge on Thursday blocked Sanofi SA and Regeneron Pharmaceuticals Inc from selling their cholesterol drug Praluent, a victory for Amgen Inc, which had accused them of infringing its patents.